graphic

Biopolis, Singapore's futuristic research hub.

How does a country one-fourth the size of Rhode Island with little history in biomedical science become one of the world's biomedical research giants? The answer: with a pile of money and a large dose of chutzpah. Since 2000, Singapore has dumped more than US$2 billion into developing a biomedical research industry—from scratch. Is the gamble paying off?

The Rockefeller University Press
2006
You do not currently have access to this content.